Soluble receptor for advanced glycation end products in patients with decreased renal function.
暂无分享,去创建一个
V. Tesar | T. Zima | M. Hodková | M. Kalousová | M. Kazderová | S. Dusilová-Sulková | M. Kalousova | J. Fialová | M. Hodkova
[1] V. Tesar,et al. Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background. , 2005, Mutation research.
[2] H. Kaneto,et al. Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications. , 2005, Diabetes care.
[3] K. Tsuneyama,et al. Expression profiling of endogenous secretory receptor for advanced glycation end products in human organs , 2005, Modern Pathology.
[4] A. D'Angelo,et al. Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension , 2005, Journal of hypertension.
[5] Merlin C. Thomas,et al. Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy. , 2005, Journal of the American Society of Nephrology : JASN.
[6] A. D'Angelo,et al. Plasma Levels of Soluble Receptor for Advanced Glycation End Products and Coronary Artery Disease in Nondiabetic Men , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[7] A. Schmidt,et al. Soluble levels of receptor for advanced glycation endproducts (sRAGE) and coronary artery disease: the next C-reactive protein? , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[8] Andrej Tarkowski,et al. Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control , 2005, Arthritis research & therapy.
[9] Hiroshi Yamamoto,et al. Roles of the receptor for advanced glycation endproducts in diabetes-induced vascular injury. , 2005, Journal of pharmacological sciences.
[10] J. Enghild,et al. Purification and Characterization of Mouse Soluble Receptor for Advanced Glycation End Products (sRAGE)* , 2004, Journal of Biological Chemistry.
[11] Ping-yan Chen,et al. Enhanced expression of receptor for advanced glycation end products in chronic kidney disease. , 2004, Journal of the American Society of Nephrology : JASN.
[12] V. Tesar,et al. Glycoxidation and inflammation in chronic haemodialysis patients. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[13] P. Rogalla,et al. Tissue-specific expression patterns of the RAGE receptor and its soluble forms--a result of regulated alternative splicing? , 2003, Biochimica et biophysica acta.
[14] C. Wanner,et al. Oxidative stress in end-stage renal disease: an emerging threat to patient outcome. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[15] S. Takasawa,et al. Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. , 2003, The Biochemical journal.
[16] R. Ouseph,et al. Effects of high-flux hemodialysis on oxidant stress. , 2003, Kidney international.
[17] T. Kislinger,et al. RAGE Blockade Stabilizes Established Atherosclerosis in Diabetic Apolipoprotein E–Null Mice , 2002, Circulation.
[18] Z. Massy,et al. Uremic Toxicity: Present State of the Art , 2001, The International journal of artificial organs.
[19] A. Schmidt,et al. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. , 2001, The Journal of clinical investigation.
[20] T. Kislinger,et al. Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. , 2001, The American journal of pathology.
[21] A. Schmidt,et al. The biology of the receptor for advanced glycation end products and its ligands. , 2000, Biochimica et biophysica acta.
[22] J. Vanherweghem,et al. Role of complement and platelet-activating factor in the stimulation of phagocytosis and reactive oxygen species production during haemodialysis. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[23] P. Jungers,et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. , 1998, Journal of immunology.
[24] P. Guillausseau,et al. Rapid Publication , 1971, Nature.
[25] A. Schmidt,et al. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. , 1995, The Journal of clinical investigation.
[26] T. Zima,et al. Lipid peroxidation on dialysis membranes. , 1993, Biochemistry and molecular biology international.